Covalon Technologies Ltd banner

Covalon Technologies Ltd
XTSX:COV

Watchlist Manager
Covalon Technologies Ltd Logo
Covalon Technologies Ltd
XTSX:COV
Watchlist
Price: 1.91 CAD -3.54% Market Closed
Market Cap: CA$52.8m

Covalon Technologies Ltd
Total Current Liabilities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Covalon Technologies Ltd
Total Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Covalon Technologies Ltd
XTSX:COV
Total Current Liabilities
CA$4.9m
CAGR 3-Years
-2%
CAGR 5-Years
-26%
CAGR 10-Years
5%
B
Bright Minds Biosciences Inc
CNSX:DRUG
Total Current Liabilities
CA$2.3m
CAGR 3-Years
54%
CAGR 5-Years
73%
CAGR 10-Years
N/A
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Total Current Liabilities
$93.7m
CAGR 3-Years
27%
CAGR 5-Years
24%
CAGR 10-Years
39%
X
Xenon Pharmaceuticals Inc
NASDAQ:XENE
Total Current Liabilities
$41.8m
CAGR 3-Years
23%
CAGR 5-Years
23%
CAGR 10-Years
31%
Eupraxia Pharmaceuticals Inc
TSX:EPRX
Total Current Liabilities
CA$5.6m
CAGR 3-Years
11%
CAGR 5-Years
-24%
CAGR 10-Years
N/A
e
enGene Holdings Inc
NASDAQ:ENGN
Total Current Liabilities
$32m
CAGR 3-Years
84%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Covalon Technologies Ltd
Glance View

Market Cap
52.8m CAD
Industry
Biotechnology

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of patent-protected medical products. The company is headquartered in Mississauga, Ontario. The company went IPO on 2004-09-03. The firm uses science and technology to help solve medical challenges associated with prevention, detection and management of areas such as infection, tissue repair and medical devices. Its products include Advanced Wound Care, Vascular Access, Perioperative Care and Urology. Advanced Wound Care is designed for the treatment of a range of wounds and offers CovaWound and ColActive brands. Vascular Access portfolio includes CovaView IV, a transparent film dressing that provides an effective barrier against external contaminants, including fluid, bacteria, and yeast. Perioperative care refers to the three Phases of surgery, including preoperative, intraoperative, and postoperative care and its brands include MediClear and SurgiClear.

COV Intrinsic Value
2.73 CAD
Undervaluation 30%
Intrinsic Value
Price CA$1.91

See Also

What is Covalon Technologies Ltd's Total Current Liabilities?
Total Current Liabilities
4.9m CAD

Based on the financial report for Dec 31, 2025, Covalon Technologies Ltd's Total Current Liabilities amounts to 4.9m CAD.

What is Covalon Technologies Ltd's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
5%

Over the last year, the Total Current Liabilities growth was 23%. The average annual Total Current Liabilities growth rates for Covalon Technologies Ltd have been -2% over the past three years , -26% over the past five years , and 5% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett